MSF to Treat Less Patients Amid Potential TPP-Triggered Drug Price Hike

Judit Rius, a legal policy adviser for the Medecins Sans Frontieres (MSF) organization, said that the Trans-Pacific Partnership (TPP) free trade agreement will have an immediate global impact, with medicine price increases, which "will make it much more difficult for MSF patients to have access to affordable medicines."